Gene Prediction Tools and Annotation Pipelines

  • Gene prediction tools and genome annotation pipelines are essential components of bioinformatics because they help identify genes and describe their structures and potential biological functions in DNA sequences. After a genome has been sequenced and assembled, researchers need to determine where genes are located, which regions encode proteins, how exons and introns are organized, and what biological roles the predicted genes may perform. These tasks are collectively part of genome annotation. Gene prediction focuses primarily on identifying gene structures, whereas genome annotation is broader and also includes the identification of noncoding RNA genes, regulatory features, repetitive sequences, functional domains, biological pathways, and other genomic elements.
  • Genome annotation generally involves two related levels: structural annotation and functional annotation. Structural annotation identifies the physical organization of genes and other genomic features, including gene boundaries, transcripts, exons, introns, coding sequences, untranslated regions, and splice sites. Functional annotation assigns biological information to predicted genes and their products, such as protein functions, conserved domains, molecular activities, biological processes, cellular locations, and pathway associations. Structural annotation usually provides the gene models that are subsequently used for functional annotation.
  • Gene prediction tools use different computational approaches to identify genes in genomic sequences. Some tools rely mainly on the statistical properties of DNA sequences, while others use similarities to known genes, proteins, or transcripts. Additional methods incorporate experimental evidence such as RNA sequencing, full-length cDNA, and proteomics data. Modern genome annotation pipelines often combine these approaches to produce more reliable gene models than any individual prediction method can provide.
  • Ab initio gene prediction tools identify genes using the statistical characteristics and biological signals present in genomic DNA. They do not require direct evidence from a known homologous gene or transcript, although they commonly require suitable training data or species-specific parameters. These tools analyse coding potential, codon usage, nucleotide composition, reading frames, start and stop codons, splice sites, and other sequence features. Hidden Markov Models and generalized Hidden Markov Models are widely used to represent gene structures and the transitions between coding and noncoding regions.
  • AUGUSTUS is a widely used eukaryotic gene prediction program. It predicts gene structures using probabilistic models and can identify coding exons, introns, splice sites, and alternative transcripts. It can operate using a predefined species model or a model trained for a particular organism. AUGUSTUS can also incorporate external evidence, often called hints, derived from transcript alignments, protein alignments, and other sources. These hints help guide predictions toward gene structures supported by biological evidence. Its flexibility makes it useful in both standalone gene prediction and larger genome annotation workflows.
  • An illustrative command for running AUGUSTUS is:

augustus \

    –species=human \

    genome.fasta \

    > augustus_predictions.gff

  • The species parameter must be replaced with an appropriate trained model for the target organism. The output contains predicted gene features in a GFF-compatible format. A predefined model from a different species should not automatically be assumed suitable for the target genome.
  • GeneMark is another important family of gene prediction tools. Different GeneMark programs are designed for different organisms and evidence types. GeneMark-ES supports self-training for eukaryotic gene prediction, while GeneMark-ET and related approaches can incorporate transcript evidence. GeneMark-EP and GeneMark-ETP use protein and combined transcript/protein evidence in supported workflows. GeneMarkS and related models are used for prokaryotic gene prediction. The choice of program depends on the organism, available evidence, and intended analysis.
  • SNAP is a gene prediction tool based on generalized Hidden Markov Models. It is commonly used for eukaryotic gene prediction and can be trained using a set of reliable gene structures from the target organism. SNAP has also been incorporated into genome annotation pipelines such as MAKER, where it contributes ab initio gene predictions that can be compared with transcript and protein evidence.
  • For prokaryotic genomes, Prodigal is a widely used gene prediction tool. It identifies protein-coding genes in bacterial and archaeal sequences by analysing coding statistics, translation initiation signals, start and stop codons, and reading frames. It is suitable for many microbial genome annotation projects and can also be used with metagenomic sequences. Its output can include predicted coding sequences, protein sequences, and gene coordinates.
  • An illustrative Prodigal command is:

prodigal \

    -i genome.fasta \

    -o predicted_genes.gff \

    -a predicted_proteins.faa \

    -d predicted_cds.fna \

    -f gff \

    -p single

  • Here, the input is a genomic FASTA file, while the outputs include gene annotations, predicted proteins, and coding DNA sequences. The single mode is intended for a typical single-genome prediction context; metagenomic data require an appropriate metagenomic configuration.
  • Other prokaryotic gene prediction tools include Glimmer and MetaGeneMark. Glimmer uses interpolated Markov models and has been applied to microbial gene prediction. MetaGeneMark is designed for gene identification in metagenomic sequence data. Prodigal, Glimmer, and MetaGeneMark are examples of tools that can identify coding regions in microbial genomes, although their performance depends on sequence quality, organism composition, and the characteristics of the dataset.
  • Homology-based gene prediction identifies genes by comparing a target genome with known DNA, RNA, or protein sequences. BLAST, DIAMOND, Exonerate, GeneWise, miniprot, and Spaln can support sequence similarity searches or sequence-to-genome alignments. Protein-to-genome alignments are particularly useful for identifying conserved coding regions and reconstructing exon structures in eukaryotic genomes. Transcript-to-genome alignments can reveal exon boundaries, splice junctions, and untranslated regions. Homology evidence is valuable, but sequence similarity alone does not prove that two genes have identical biological functions.
  • Transcript-based gene prediction uses RNA-derived evidence to identify expressed genomic regions and reconstruct gene structures. RNA sequencing produces reads that can be aligned to a reference genome to identify exons and splice junctions. HISAT2 and STAR are widely used RNA-seq alignment tools, while StringTie and other transcript assemblers can reconstruct transcript structures from aligned reads. Long-read technologies such as PacBio Iso-Seq and Oxford Nanopore sequencing can provide longer transcript sequences, which are particularly useful for identifying complete or complex transcript isoforms.
  • Protein evidence provides additional support for gene prediction. Known protein sequences can be aligned to genomic DNA or predicted protein sequences to identify conserved coding regions and protein domains. Proteomics data generated through mass spectrometry can provide experimental evidence that particular gene products are translated. However, the absence of transcript or protein evidence does not necessarily indicate that a gene is absent. Expression can be restricted to specific tissues, developmental stages, environmental conditions, or biological states.
  • Integrated gene prediction pipelines combine several computational methods and evidence sources to produce genome annotations. Rather than relying exclusively on ab initio prediction, these pipelines may incorporate protein homology, transcript alignments, RNA-seq reads, long-read transcript data, repeat masking, and functional annotation. They are particularly useful for newly sequenced organisms for which complete and reliable gene annotations are not available.
  • BRAKER is an important automated pipeline for eukaryotic gene prediction. It combines GeneMark and AUGUSTUS with external evidence such as RNA-seq and protein sequences. Depending on the available data and configuration, it can use transcript or protein evidence to support model training and final gene prediction. BRAKER3 combines GeneMark-ETP and AUGUSTUS and can use RNA-seq and protein evidence. BRAKER4 is a newer implementation of the BRAKER workflow, using Snakemake and supporting transcriptome and protein evidence. Researchers should select the appropriate release and follow its corresponding installation and input requirements rather than treating all BRAKER versions as interchangeable.
  • A conceptual BRAKER workflow includes a genome assembly, optional repeat masking, preparation of transcript or protein evidence, evidence alignment, model training, gene prediction, and quality assessment. The exact input files and configuration depend on the BRAKER version and evidence supplied. A simplified command-line illustration is:

braker.pl \

    –genome=genome.fasta \

    –prot_seq=reference_proteins.fasta \

    –workingdir=braker_output

  • This illustrates the general idea of supplying a genome and protein evidence to a BRAKER workflow. It is not a universal command for every release. Actual execution may require additional parameters, software dependencies, supported evidence formats, species information, and configuration appropriate to the installed version. RNA-seq evidence can be supplied through the relevant input options when supported by the selected release.
  • MAKER is another established genome annotation pipeline that integrates ab initio gene predictions with transcript and protein evidence. It can use ESTs, cDNA sequences, protein alignments, and predictions from programs such as AUGUSTUS and SNAP. MAKER evaluates these sources and helps generate gene models supported by multiple forms of evidence. It can also assist with training gene predictors and refining annotations through successive rounds of analysis. This makes it useful for genome projects in which evidence and gene models are improved iteratively.
  • EVidenceModeler (EVM) combines gene predictions and sequence alignment evidence into consensus gene structures. It accepts evidence such as ab initio predictions, protein alignments, and transcript alignments, together with weights assigned to different evidence types. The weighting system allows researchers to give greater influence to evidence sources considered more reliable for a particular organism or project. EVM is often used as part of a broader annotation workflow rather than as a complete standalone solution for every stage of genome annotation.
  • Funannotate is a genome annotation pipeline designed particularly for eukaryotic genomes, including fungal genomes. It integrates several tools for repeat identification, gene prediction, functional annotation, and quality assessment. Depending on its configuration and supported software, it can use evidence from transcripts and proteins, run gene prediction programs, and assign functional descriptions to predicted proteins. It is useful for projects that require a coordinated workflow from genome preparation to annotated gene sets.
  • NCBI’s Eukaryotic Genome Annotation Pipeline provides another important approach to genome annotation. It combines computational methods and available biological evidence to annotate eukaryotic genome assemblies submitted to NCBI. NCBI also provides the Prokaryotic Genome Annotation Pipeline (PGAP) for bacterial and archaeal genome annotation. PGAP identifies genes and other genomic features and assigns functional information using established computational methods and reference resources. These pipelines are important for standardized genome annotation and for producing records suitable for public database submission.
  • A typical genome annotation pipeline begins with genome assembly assessment. The quality and completeness of the assembly influence the reliability of every subsequent annotation step. Researchers examine contig and scaffold lengths, assembly continuity, contamination, duplicated sequences, and completeness of expected conserved genes. Tools such as QUAST can help assess assembly statistics, while BUSCO can evaluate the presence of conserved single-copy orthologs. These assessments do not prove that an assembly is error-free, but they provide useful information about its suitability for annotation.
  • Repeat identification and masking are often performed before gene prediction, especially in eukaryotic genomes. Repetitive elements include transposable elements, tandem repeats, simple sequence repeats, and other repeated DNA regions. Some repeats contain sequences that resemble coding regions and may generate false gene predictions. RepeatModeler can help identify and classify repeat families, while RepeatMasker can identify and mask matching repetitive sequences. Soft masking replaces or marks repetitive bases in a way that preserves the original sequence information, whereas hard masking replaces them with ambiguous characters. The masking strategy should be selected carefully because some genuine genes may overlap repetitive elements or contain repeated domains.
  • The next stage involves collecting and preparing evidence for gene prediction. This may include protein sequences from related organisms, RNA-seq reads, assembled transcripts, full-length cDNA sequences, ESTs, and available curated gene annotations. The selection of evidence should reflect the evolutionary relationship between the target organism and the reference species. Closely related reference proteins are often useful, but using sequences from several related organisms can improve coverage of conserved gene families. Transcript data should ideally represent relevant tissues, developmental stages, and environmental conditions.
  • Evidence alignment is then performed to map proteins and transcripts to the target genome. Protein alignments help identify conserved coding regions, while transcript alignments reveal expressed exons and splice junctions. RNA-seq reads can be aligned using STAR or HISAT2, and long transcripts can be mapped using tools such as minimap2. The resulting alignments can be processed into evidence tracks or annotation files that are used by gene prediction programs. Alignment quality, coverage, mapping ambiguity, and the presence of unsupported junctions should be examined before the evidence is incorporated into gene models.
  • Ab initio gene prediction is often performed alongside evidence alignment or after an initial evidence collection stage. Tools such as AUGUSTUS, GeneMark, SNAP, and Prodigal identify candidate gene structures using their respective statistical models. For eukaryotic genomes, the models may be trained using high-confidence gene structures from the target organism or related species. For microbial genomes, coding sequence characteristics and translation initiation signals are particularly important. The selected predictor must be appropriate for the organism and genome type.
  • Evidence integration combines the predictions and alignments into a more complete gene set. A pipeline may use transcript-supported exon boundaries, protein-supported coding regions, and ab initio predictions to reconstruct gene structures. Consensus methods such as EVidenceModeler can combine different evidence types using weights. Some pipelines also apply filters to remove unsupported or low-confidence predictions. However, combining several predictions does not automatically guarantee accuracy. If evidence sources share the same underlying errors, their agreement may provide less independent support than it appears to.
  • Functional annotation follows structural gene prediction. Predicted coding sequences are translated into protein sequences, which can then be compared with known proteins and conserved domain databases. BLAST and DIAMOND can identify similar proteins, while InterProScan can detect conserved protein domains, families, and functional sites by using integrated resources. Pfam, InterPro, and the NCBI Conserved Domain Database provide information about protein families and domains. Gene Ontology terms can describe molecular functions, biological processes, and cellular components, while KEGG and Reactome can support pathway-level interpretation where suitable organism coverage is available.
  • Functional annotation may also use resources such as UniProtKB, RefSeq, eggNOG, and orthology databases. Protein descriptions, enzyme classifications, conserved motifs, and pathway associations can provide useful functional information. However, annotation transfer must be interpreted carefully. A protein sequence that resembles a known protein may share only a domain or family relationship rather than an identical biological function. Functional predictions should therefore be assigned with appropriate confidence and evidence labels, especially when they are based on computational similarity alone.
  • Noncoding RNA annotation is another important part of genome annotation. Genomes contain transfer RNAs, ribosomal RNAs, small nuclear RNAs, microRNAs, long noncoding RNAs, and other RNA molecules that do not necessarily encode proteins. Tools such as tRNAscan-SE can identify transfer RNA genes, while Infernal can search for structured RNA families using covariance models and resources such as Rfam. Ribosomal RNA genes can be identified using specialized sequence analysis tools and databases. Noncoding RNA annotation is often performed separately from protein-coding gene prediction because these RNA classes have distinct sequence and structural characteristics.
  • Genome annotation pipelines also need to identify pseudogenes, fragmented genes, gene duplications, and possible contamination. Pseudogenes may resemble functional genes but have lost some or all of their original protein-coding capacity. They can arise through gene duplication or retrotransposition and may contain frameshifts, premature stop codons, or disrupted regulatory regions. Fragmented gene predictions may result from assembly gaps, sequencing errors, incomplete evidence, or genuine gene structure complexity. These cases require careful interpretation rather than automatic removal.
  • Quality assessment is essential for evaluating the completeness and reliability of predicted gene sets. BUSCO is widely used to assess genome assemblies and predicted protein sets by examining conserved orthologous genes expected to be present in a particular lineage. High BUSCO completeness can indicate that many expected conserved genes have been recovered, but it does not establish that every gene model is correct. Other assessments may compare gene predictions with RNA-seq data, protein evidence, known annotations, and independent reference datasets. Metrics such as sensitivity, precision, exon-level accuracy, splice-junction accuracy, and complete-gene accuracy can provide more detailed information about prediction performance.
  • The final structural annotation is commonly stored in GFF3 or GTF format, while predicted proteins and coding sequences are stored in FASTA files. A genome annotation project may also produce functional annotation tables, repeat annotations, noncoding RNA records, evidence files, and quality-control reports. Gene identifiers should be consistent across files, and the relationships between genes, transcripts, exons, and coding sequences should be represented correctly. The genome assembly version must also be recorded because genomic coordinates are meaningful only in relation to a specific assembly.
  • A simplified workflow for eukaryotic genome annotation can be represented as follows: genome assembly assessment, repeat identification and masking, evidence collection, protein and transcript alignment, ab initio gene prediction, evidence integration, functional annotation, noncoding RNA identification, quality assessment, and final annotation export. The order and implementation of these stages can vary according to the pipeline and organism. For example, BRAKER integrates gene prediction and evidence-supported model training, whereas MAKER and Funannotate coordinate several annotation components within broader workflows.
  • For microbial genome annotation, the workflow is generally more compact because bacterial and archaeal genes typically have simpler structures than many eukaryotic genes. A common approach includes assembly assessment, coding sequence prediction using Prodigal or a suitable alternative, identification of ribosomal and transfer RNA genes, functional annotation of predicted proteins, and quality assessment. For metagenomic datasets, the workflow must also consider mixed species, incomplete genomes, sequence composition differences, and the possibility that contigs originate from organisms with different genetic characteristics.
  • Reproducibility is essential in genome annotation because different tools, databases, parameter settings, and reference assemblies can produce different gene sets. Researchers should record the genome assembly accession and version, software versions, reference database versions, training models, command-line parameters, evidence sources, and dates of database retrieval. Workflow managers such as Snakemake and Nextflow can organize complex annotation analyses, manage dependencies, and support reproducible execution. Containers such as Docker and Apptainer can help preserve software environments, particularly when analyses are conducted on high-performance computing systems.
  • Genome annotation also requires appropriate data management and documentation. Raw sequencing data, genome assemblies, evidence alignments, predicted gene models, and functional annotations should be retained separately. Intermediate files should not be confused with final curated annotations. A clear distinction should be maintained between experimentally validated genes, computationally predicted gene structures, and functional descriptions inferred from sequence similarity. This is especially important when genome annotations are used in evolutionary studies, disease research, agricultural genetics, or comparative genomics.
  • The selection of gene prediction tools and annotation pipelines depends on the organism, genome size, assembly quality, available transcript and protein evidence, computational resources, and research objectives. For eukaryotic genomes, AUGUSTUS, GeneMark, BRAKER, MAKER, Funannotate, and EVidenceModeler can contribute to different stages of annotation. For prokaryotic genomes, Prodigal, Glimmer, GeneMarkS, and NCBI PGAP are relevant options. For RNA evidence, STAR, HISAT2, StringTie, and long-read alignment tools support transcript reconstruction. For functional annotation, BLAST, DIAMOND, InterProScan, eggNOG, and other databases and tools provide complementary information.
  • No single tool can guarantee a complete and accurate genome annotation. The most reliable results generally come from combining high-quality genome assemblies, suitable gene prediction models, relevant transcript and protein evidence, functional databases, and independent quality assessments. Careful selection of tools, appropriate interpretation of evidence, and transparent reporting of limitations are essential for producing biologically meaningful genome annotations.
  • Gene prediction tools and annotation pipelines have transformed the analysis of newly sequenced genomes. They enable researchers to move from raw genomic sequences to structured gene models and functional descriptions that can be used in downstream biological investigations. As sequencing technologies, computational algorithms, and reference databases continue to improve, integrated annotation pipelines will remain central to bioinformatics, genomics, evolutionary biology, biotechnology, medicine, and agricultural research.
Author:

Leave a Reply

Your email address will not be published. Required fields are marked *